Please use this identifier to cite or link to this item:
|Title: ||Study protocol: a double blind randomised control trial of high volume image guided injections in achilles and patellar tendinopathy in a young active population|
|Authors: ||Barker-Davies, Robert M.|
Wheeler, Patrick C.
Fong, Daniel Tik-Pui
Lewis, Mark P.
Bennett, Alexander N.
|Issue Date: ||2017|
|Publisher: ||© The Authors. Published by Biomed Central.|
|Citation: ||BARKER-DAVIES, R.M. ...et al., 2017. Study protocol: a double blind randomised control trial of high volume image guided injections in achilles and patellar tendinopathy in a young active population. BMC Musculoskeletal Disorders, 18:204.|
|Abstract: ||Background: Chronic tendinopathy is a significant problem particularly in active populations limiting sporting and
occupational performance. The prevalence of patellar tendinopathy in some sports is near 50% and the incidence
of lower limb tendinopathy is 1.4% p.a. in the UK Military. Management includes isometric, eccentric, heavy slow
resistance exercises and extracorporeal shockwave therapy (ESWT). Often these treatments are inadequate yet there
is no good evidence for injection therapies and success rates from surgery can be as low as 50%. High Volume Image Guided Injection (HVIGI) proposes to strip away the neovascularity and disrupt the nerve
ingrowth seen in chronic cases and has shown promising results in case series. This study aims to investigate the efficacy of HVIGI in a randomised controlled trial (RCT).
Methods: RCT comparing 40ml HVIGI, with or without corticosteroid, with a 3ml local anaesthetic sham-control injection. Ninety-six participants will be recruited. Inclusion criteria: male, 18–55 years old, chronic Achilles or patellar tendinopathy of at least 6 months, failed conservative management including ESWT, and Ultrasound (US) evidence of neovascularisation, tendon thickening and echogenic changes. Outcome measures will be recorded at baseline, 6 weeks, 3, 6 and 12 months. Primary outcome measures include The Victoria Institute of Sport Assessments for Achilles and patellar tendinopathy (VISA-A and VISA-P) and VAS pain. Secondary outcome measures include
Modified Ohberg score, maximum tendon diameter and assessment of hypoechoic appearance on US, and Functional Activity Assessment.
Discussion: Despite previous interventional trials and reviews there is still insufficient evidence to guide injectable
therapy for chronic tendinopathy that has failed conservative treatment. The scant evidence available suggests HVIGI has the greatest potential however there is no level one RCT evidence to support this. Investigating the efficacy of HVIGI against control in a RCT and separating the effect of HVIGI and corticosteroid will add high level
evidence to the management of chronic tendinopathy resistant to conservative treatment.|
|Description: ||This is an Open Access Article. It is published by BioMed Central under the Creative Commons Attribution 4.0 Unported Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/|
|Sponsor: ||This study has attracted funding through Loughborough University from the
Higher Education Funding Council for England and a PhD Studentship.|
|Publisher Link: ||http://dx.doi.org/10.1186/s12891-017-1564-7|
|Appears in Collections:||Published Articles (Sport, Exercise and Health Sciences)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.